Brain-derived neurotrophic factor regulates early postnatal developmental cell death of dopamine neurons of the substantia nigra in vivo

Molecular and Cellular Neuroscience

Volumn 41, Issue 4, 2009, Pages 440-447

  Oo, Tinmarla F ^a   Marchionini, Deanna M ^a   Yarygina, Olga ^a   O'Leary, Paul D ^b   Hughes, Richard A ^c   Kholodilov, Nikolai ^a   Burke, Robert E ^a  

^a Columbia University ^*  (United States)

^b Metabolic Pharmaceuticals Ltd   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; WESTERN BLOTTING;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; DOPAMINE; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU NICK-END LABELING; INTERMEDIATE FILAMENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; PEPTIDES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS; RATTUS;

EID: 67349100946     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.04.009     Document Type: Article

References (49)

1. Acheson A., Conover J.C., Fandl J.P., DeChiara T.M., Russell M., Thadani A., Squinto S.P., Yancopoulos G.D., and Lindsay R.M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374 (1995) 450-453
2. Alonso-Vanegas M.A., Fawcett J.P., Causing C.G., Miller F.D., and Sadikot A.F. Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse. J. Comp. Neurol. 413 (1999) 449-462
3. Altar C.A., and DiStefano P.S. Neurotrophin trafficking by anterograde transport. Trends Neurosci. 21 (1998) 433-437
4. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., and Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389 (1997) 856-860
5. Baker S.A., Stanford L.E., Brown R.E., and Hagg T. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice. Brain Res. 1039 (2005) 177-188
6. Baquet Z.C., Bickford P.C., and Jones K.R. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J. Neurosci. 25 (2005) 6251-6259
7. Barde Y.A., Edgar D., and Thoenen H. Sensory neurons in culture: changing requirements for survival factors during embryonic development. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 1199-1203
8. Barde Y.A., Edgar D., and Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1 (1982) 549-553
9. Burke R.E., Franklin S.O., and Inturrisi C.E. Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injury. J. Neurochem. 62 (1994) 1878-1886
10. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., and Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17 (1997) 2295-2313
11. El-Khodor B.F., and Burke R.E. Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J. Comp. Neurol. 452 (2002) 65-79
12. Ernfors P., Kuo-Fen L., and Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368 (1994) 147-150
13. Ganguly A., Oo T.F., Rzhetskaya M., Pratt R., Yarygina O., Momoi T., Kholodilov N., and Burke R.E. CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine. J. Neurochem. 88 (2004) 469-480
14. Gerfen C.R., Herkenham M., and Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7 (1987) 3915-3934
15. Heller A., Hutchens J.O., Kirby M.L., Karapas F., and Fernandez C. Stereotaxic electrode placement in the neonatal rat. J. Neurosci. Methods 1 (1979) 41-76
16. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., and Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350 (1991) 230-232
17. Jackson-Lewis V., Vila M., Djaldetti R., Guegan C., Liberatore G., Liu J., O'Malley K.L., Burke R.E., and Przedborski S. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J. Comp. Neurol. 424 (2000) 476-488
18. Jain S., Golden J.P., Wozniak D., Pehek E., Johnson Jr. E.M., and Milbrandt J. RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J. Neurosci. 26 (2006) 11230-11238
19. Janec E., and Burke R.E. Naturally occurring cell death during postnatal development of the substantia nigra of the rat. Mol. Cell. Neurosci. 4 (1993) 30-35
20. Jarskog L.F., Miyamoto S., and Lieberman J.A. Schizophrenia: new pathological insights and therapies. Annu. Rev. Med. 58 (2007) 49-61
21. Jeon B.S., Kholodilov N.G., Oo T.F., Kim S., Tomaselli K.J., Srinivasan A., Stefanis L., and Burke R.E. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J. Neurochem. 73 (1999) 322-333
22. Jones K.R., Farinas I., Backus C., and Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76 (1994) 989-999
23. Kauer J.A., and Malenka R.C. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8 (2007) 844-858
24. Kerr D.A., Llado J., Shamblott M.J., Maragakis N.J., Irani D.N., Crawford T.O., Krishnan C., Dike S., Gearhart J.D., and Rothstein J.D. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J. Neurosci. 23 (2003) 5131-5140
25. Kholodilov N., Yarygina O., Oo T.F., Zhang H., Sulzer D., Dauer W.T., and Burke R.E. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J. Neurosci. 24 (2004) 3136-3146
26. Klein R., Smeyne R.J., Wurst W., Long L.K., Auerbach B.A., Joyner A.L., and Barbacid M. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75 (1993) 113-122
27. Kramer E.R., Aron L., Ramakers G.M., Seitz S., Zhuang X., Beyer K., Smidt M.P., and Klein R. Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol. 5 (2007) e39
28. Lauder J.M., and Bloom F.E. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. J. Comp. Neurol. 155 (1974) 469-482
29. Lee M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
30. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., and Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341 (1989) 149-152
31. Lindsay R.M. Brain-derived neurotrophic factor: an NGF-related neurotrophin. In: Loughlin S.E., and Fallon J.H. (Eds). Neurotrophic Factors (1993), Academic Press, San Diego 257-284
32. Macaya A., Munell F., Gubits R.M., and Burke R.E. Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8117-8121
33. Maisonpierre P.C., Belluscio L., Friedman B., Alderson R.F., Wiegand S.J., Furth M.E., Lindsay R.M., and Yancopoulos G.D. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5 (1990) 501-509
34. Marchand R., and Poirer L.J. Isthmic origin of neurons of the rat substantia nigra. Neuroscience 9 (1983) 373-381
35. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., and Schwartz M.W. Central nervous system control of food intake and body weight. Nature 443 (2006) 289-295
36. Neystat M., Rzhetskaya M., Oo T.F., Kholodilov N., Yarygina O., Wilson A., El-Khodor B.F., and Burke R.E. Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo. J. Neurochem. 77 (2001) 1611-1625
37. Numan S., and Seroogy K.B. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403 (1999) 295-308
38. Numan S., Gall C.M., and Seroogy K.B. Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain. J. Mol. Neurosci. 27 (2005) 245-260
39. O'Leary P.D., and Hughes R.A. Structure-activity relationships of conformationally constrained peptide analogues of loop 2 of brain-derived neurotrophic factor. J. Neurochem. 70 (1998) 1712-1721
40. Oo T.F., and Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev. Brain Res. 98 (1997) 191-196
41. Oo T.F., Kholodilov N., and Burke R.E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal GDNF in vivo. J. Neurosci. 23 (2003) 5141-5148
42. Oppenheim R.W. Cell death during development of the nervous system. Ann. Rev. Neurosci. 14 (1991) 453-501
43. Pascual A., Hidalgo-Figueroa M., Piruat J.I., Pintado C.O., Gomez-Diaz R., and Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat. Neurosci. 11 (2008) 755-761
44. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, New York
45. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, San Diego, CA
46. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., and Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15 (2001) 1748-1757
47. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., and Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342 (1994) 321-334
48. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., and Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59 (1992) 99-106
49. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 (1999) 99-103